MCMCB Pro
J2791

J2791Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

HCPCSActiveBETOS O1E

J2791 is a HCPCS Level II code for injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J2791 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
15 units
MAI 3 — Date of Service Edit: Clinical · Clinical: Data
outpatient
15 units
MAI 3 — Date of Service Edit: Clinical · Clinical: Data

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J2791

Long descriptor
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu

The official wording. This is what the code means.

Short descriptor
Rhophylac injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2008

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J2791

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2791 is not quite right, the correct code is very often within a few positions of it.

  • J2782Injection, avacincaptad pegol, 0.1 mg
  • J2783Injection, rasburicase, 0.5 mg
  • J2785Injection, regadenoson, 0.1 mg
  • J2786Injection, reslizumab, 1 mg
  • J2787Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
  • J2788Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)
  • J2789Riboflavin 5'-phosphate, ophthalmic solution (epioxahd/epioxa), up to 2 ml
  • J2790Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)
  • J2792Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu
  • J2793Injection, rilonacept, 1 mg
  • J2794Injection, risperidone (risperdal consta), 0.5 mg
  • J2795Injection, ropivacaine hydrochloride, 1 mg
  • J2796Injection, romiplostim, 10 microgramsterminated
  • J2797Injection, rolapitant, 0.5 mg
  • J2798Injection, risperidone, (perseris), 0.5 mg
  • J2799Injection, risperidone (uzedy), 1 mg

Questions about J2791

What is HCPCS code J2791?

J2791 is a HCPCS Level II code for injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J2791?

The CMS HCPCS file marks J2791 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J2791 paid under the physician fee schedule?

J2791 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026